Boquimpani, C., Seguro, F. S., Magalhães, G. H. R., Pinto, I. L. S., Bendit, I., Bortolini, J. A. P., . . . Funke, V. (2022). Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice.
Citación estilo ChicagoBoquimpani, Carla, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit, Jaisson André Pagnoncelli Bortolini, Katia Borgia Barbosa Pagnano, Renato Centrone, y Vaneuza Funke. Brazilian Chronic Myeloid Leukemia Working Group Recommendations for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia in Clinical Practice. 2022.
Cita MLABoquimpani, Carla, et al. Brazilian Chronic Myeloid Leukemia Working Group Recommendations for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia in Clinical Practice. 2022.